Aubrey Masango speaks to Dr Chris Hendriks, chief medical officer at Decentra Health and chief community impact officer at A Rare Cause, to discuss the state of rare diseases in South Africa.

He also unpacks the efforts being made to support patients and families.

 

You’re listening to The Aubrey Masango Show with Aubrey Masango, where real conversations meet expert insights – from politics, to life, personal finance, and more.

Catch the show live on 702 weekdays from 8 pm to midnight, or on CapeTalk from 8 pm to 9 pm (South African time)

Thanks for listening.

Find more from the show and catch-up podcasts on Primedia+ and subscribe to the 702 newsletters for more.

 

Let's keep the conversation going online:

702 on Facebook: https://www.facebook.com/TalkRadio702 
702 on TikTok: https://www.tiktok.com/@talkradio702 
702 on Instagram: https://www.instagram.com/talkradio702/ 
702 on X: https://x.com/Radio702 
702 on YouTube: https://www.youtube.com/@radio702 

CapeTalk on Facebook: https://www.facebook.com/CapeTalk 
CapeTalk on TikTok: https://www.tiktok.com/@capetalk 
CapeTalk on Instagram: https://www.instagram.com/ 
CapeTalk on X: https://x.com/CapeTalk 

CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567

Aubrey Masango speaks to Dr Chris Hendriks, chief medical officer at Decentra Health and chief community impact officer at A Rare Cause, to discuss the state of rare diseases in South Africa.
He also unpacks the efforts being made to support patients and families.
&nbsp;
You&rsquo;re listening to The Aubrey Masango Show with Aubrey Masango, where real conversations meet expert insights &ndash; from politics, to life, personal finance, and more.
Catch the show live on <a href="https://www.primediaplus.com/702/the-aubrey-masango-show/">702</a> weekdays from 8 pm to midnight, or on <a href="https://www.primediaplus.com/capetalk/the-aubrey-masango-show/">CapeTalk</a> from 8 pm to 9 pm (South African time)
Thanks for listening.
Find more from the show and catch-up podcasts on <a href="https://www.primediaplus.com/702/the-aubrey-masango-show/">Primedia+</a> and subscribe to the <a href="https://buff.ly/v5mfetc">702 newsletters</a> for more.
&nbsp;
Let's keep the conversation going online:
702 on Facebook:&nbsp;<a href="https://www.facebook.com/TalkRadio702">https://www.facebook.com/TalkRadio702</a>&nbsp; 702 on TikTok:&nbsp;<a href="https://www.tiktok.com/@talkradio702">https://www.tiktok.com/@talkradio702</a>&nbsp; 702 on Instagram:&nbsp;<a href="https://www.instagram.com/talkradio702/">https://www.instagram.com/talkradio702/</a>&nbsp; 702 on X:&nbsp;<a href="https://x.com/Radio702">https://x.com/Radio702</a>&nbsp; 702 on YouTube:&nbsp;<a href="https://www.youtube.com/@radio702">https://www.youtube.com/@radio702</a>&nbsp;
CapeTalk&nbsp;on Facebook:&nbsp;<a href="https://www.facebook.com/CapeTalk">https://www.facebook.com/CapeTalk</a>&nbsp; CapeTalk on TikTok:&nbsp;<a href="https://www.tiktok.com/@capetalk">https://www.tiktok.com/@capetalk</a>&nbsp; CapeTalk on Instagram:&nbsp;<a href="https://www.instagram.com/">https://www.instagram.com/</a>&nbsp; CapeTalk on X:&nbsp;<a href="https://x.com/CapeTalk">https://x.com/CapeTalk</a>&nbsp;
CapeTalk&nbsp;on YouTube:&nbsp;<a href="https://www.youtube.com/@CapeTalk567">https://www.youtube.com/@CapeTalk567</a>

Unpack the stories of the day in depth with Aubrey’s considered opinions, peppered with audience perspectives.

The Aubrey Masango Show

Weekdays 8 pm - Midnight

Aubrey constantly looks for conversations aimed at unlocking the humanity and potential of each individual and collective in realising their goals.

Follow Aubrey on @BraAubrey

Weekdays 8 pm - Midnight
Aubrey constantly looks for conversations aimed at unlocking the humanity and potential of each individual and collective in realising their goals.
Follow Aubrey on&nbsp;<a href="https://twitter.com/BraAubrey">@BraAubrey</a>

Medical Matters: Why rare diseases affect millions and are still overlooked

https://api.omny.fm/orgs/5dcefa8e-00a9-4595-8ce1-a4ab0080f142/clips/fe66e609-fbdb-44d6-9a7c-b4010138dd1a/transcript